Related Experiment Video
Updated: Dec 25, 2025

Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
Defining Pneumonia Severity in Children: A Delphi Study
Preston Dean1, Daniel Schumacher, Todd A Florin
1From the Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center.
Insights
Experts established consensus on factors for classifying pediatric community-acquired pneumonia (CAP) severity. This work aids in developing standardized risk stratification tools for childhood CAP management.
Area of Science:
- Pediatric infectious diseases
- Clinical epidemiology
- Respiratory medicine
Background:
- Community-acquired pneumonia (CAP) is a common childhood infection.
- Current management lacks standardized risk classification for pediatric CAP.
- Need for objective criteria to guide treatment decisions.
Purpose of the Study:
- To achieve expert consensus on factors determining severity in pediatric CAP.
- To identify clinical, radiographic, and laboratory indicators of disease severity.
- To inform the development of risk stratification tools for pediatric CAP.
Main Methods:
- Utilized a web-based Delphi process with 10 pediatric pneumonia experts.
- Experts rated clinical, radiographic, laboratory factors, and outcomes on a 9-point Likert scale.
- Consensus defined as ≥70% agreement on severity (mild, moderate, severe).
Main Results:
- Consensus reached on 286 of 318 identified factors (90%).
- Key clinical factors included age, oxygen saturation, respiratory rate, and gestational age.
- Imaging, lab findings, hospitalization, and respiratory support needs were critical for severity classification.
Conclusions:
- Expert consensus identified key factors for pediatric CAP risk stratification.
- This study provides a foundation for developing standardized severity criteria.
- Informs future research for clinically meaningful risk stratification scores in pediatric CAP.
Objectives:
Although community-acquired pneumonia (CAP) is one of the most common infections in children, no standardized risk classification exists to guide management. The objective of this study was to develop expert consensus for factors associated with various degrees of disease severity in pediatric CAP.
Methods:
Using a web-based classical Delphi process, a multidisciplinary panel of 10 childhood pneumonia experts rated the degree of severity (mild, moderate, or severe) of clinical, radiographic, and laboratory factors, as well as outcomes relevant to pediatric pneumonia. Round 1 was open-ended, with panelists freely stating all characteristics they felt determined pneumonia severity. In rounds 2 to 4, panelists used a 9-point Likert scale (1-3, mild; 4-6, moderate; 7-9, severe) to rate severity for each item. Consensus was defined as 70% or greater agreement in ranking mild, moderate, or severe.
Results:
Panelists identified 318 factors or outcomes in round 1; the panel reached consensus for 286 (90%). The majority of items without consensus straddled levels of severity (eg, mild-moderate). Notable clinical factors with consensus included age, oxygen saturation, age-based respiratory rate, and gestational age. Severity classification consensus was also reached for specific imaging and laboratory findings. Need for and duration of hospitalization, supplemental oxygen/respiratory support, and intravenous fluids/medications were considered important outcomes in classifying severity.
Conclusions:
This study presents factors deemed important for risk stratification in pediatric CAP by consensus of a multidisciplinary expert panel. This initial step toward identifying and formalizing severity criteria for CAP informs critical knowledge gaps and can be leveraged in future development of clinically meaningful risk stratification scores.
More Related Videos
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
07:43A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
Published on: September 28, 2016
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...